Annual CFI
-$1.16 M
+$321.80 K+21.76%
April 30, 2024
Summary
- As of February 8, 2025, IPA annual cash flow from investing activities is -$1.16 million, with the most recent change of +$321.80 thousand (+21.76%) on April 30, 2024.
- During the last 3 years, IPA annual CFI has risen by +$719.40 thousand (+38.33%).
- IPA annual CFI is now -122.74% below its all-time high of $5.09 million, reached on December 31, 2010.
Performance
IPA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$48.20 K
+$143.80 K+74.90%
October 31, 2024
Summary
- As of February 8, 2025, IPA quarterly cash flow from investing activities is -$48.20 thousand, with the most recent change of +$143.80 thousand (+74.90%) on October 31, 2024.
- Over the past year, IPA quarterly CFI has increased by +$143.80 thousand (+74.90%).
- IPA quarterly CFI is now -100.95% below its all-time high of $5.09 million, reached on December 1, 2010.
Performance
IPA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$1.02 M
+$179.00 K+14.89%
October 31, 2024
Summary
- As of February 8, 2025, IPA TTM cash flow from investing activities is -$1.02 million, with the most recent change of +$179.00 thousand (+14.89%) on October 31, 2024.
- Over the past year, IPA TTM CFI has increased by +$179.00 thousand (+14.89%).
- IPA TTM CFI is now -120.10% below its all-time high of $5.09 million, reached on December 1, 2010.
Performance
IPA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
IPA Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +21.8% | +74.9% | +14.9% |
| 3 y3 years | +38.3% | +74.9% | +14.9% |
| 5 y5 years | +30.7% | +74.9% | +14.9% |
IPA Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +72.1% | -220.2% | +98.5% | -49.5% | +78.5% |
| 5 y | 5-year | at high | +72.1% | -220.2% | +98.5% | -49.5% | +78.5% |
| alltime | all time | -122.7% | +79.4% | -101.0% | +98.5% | -120.1% | +81.8% |
ImmunoPrecise Antibodies Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2024 | - | -$48.20 K(-74.9%) | -$1.02 M(-14.9%) |
| Jul 2024 | - | -$192.00 K(-76.7%) | -$1.20 M(+3.8%) |
| Apr 2024 | -$1.16 M(-21.8%) | -$822.80 K(-2151.9%) | -$1.16 M(+69.1%) |
| Jan 2024 | - | $40.10 K(-117.6%) | -$684.40 K(-22.2%) |
| Oct 2023 | - | -$227.20 K(+54.0%) | -$879.40 K(-43.5%) |
| Jul 2023 | - | -$147.50 K(-57.8%) | -$1.56 M(+5.3%) |
| Apr 2023 | -$1.48 M(-64.4%) | -$349.80 K(+125.8%) | -$1.48 M(-66.4%) |
| Jan 2023 | - | -$154.90 K(-82.9%) | -$4.40 M(-7.7%) |
| Oct 2022 | - | -$905.30 K(+1210.1%) | -$4.77 M(+20.9%) |
| Jul 2022 | - | -$69.10 K(-97.9%) | -$3.94 M(-5.0%) |
| Apr 2022 | -$4.15 M(+121.2%) | -$3.27 M(+527.4%) | -$4.15 M(+179.8%) |
| Jan 2022 | - | -$521.30 K(+536.5%) | -$1.48 M(+16.1%) |
| Oct 2021 | - | -$81.90 K(-70.4%) | -$1.28 M(-27.0%) |
| Jul 2021 | - | -$276.70 K(-54.1%) | -$1.75 M(-6.7%) |
| Apr 2021 | -$1.88 M(+58.3%) | -$603.40 K(+90.9%) | -$1.88 M(+46.0%) |
| Jan 2021 | - | -$316.10 K(-43.0%) | -$1.29 M(-33.9%) |
| Oct 2020 | - | -$554.50 K(+37.7%) | -$1.95 M(+27.4%) |
| Jul 2020 | - | -$402.80 K(+3342.7%) | -$1.53 M(+28.8%) |
| Apr 2020 | -$1.19 M(-29.0%) | -$11.70 K(-98.8%) | -$1.19 M(-28.3%) |
| Jan 2020 | - | -$976.30 K(+615.8%) | -$1.65 M(+6.1%) |
| Oct 2019 | - | -$136.40 K(+122.1%) | -$1.56 M(-9.3%) |
| Jul 2019 | - | -$61.40 K(-87.2%) | -$1.72 M(+2.8%) |
| Apr 2019 | -$1.67 M(-70.3%) | -$479.60 K(-45.6%) | -$1.67 M(-58.4%) |
| Jan 2019 | - | -$881.30 K(+197.9%) | -$4.01 M(+25.8%) |
| Oct 2018 | - | -$295.80 K(+1968.5%) | -$3.19 M(-42.0%) |
| Jul 2018 | - | -$14.30 K(-99.5%) | -$5.49 M(-2.2%) |
| Apr 2018 | -$5.62 M(+4139.1%) | -$2.82 M(+4781.0%) | -$5.62 M(+100.8%) |
| Jan 2018 | - | -$57.80 K(-97.8%) | -$2.80 M(+2.1%) |
| Oct 2017 | - | -$2.60 M(+1753.0%) | -$2.74 M(+2098.9%) |
| Jul 2017 | - | -$140.40 K(-994.3%) | -$124.70 K(-894.3%) |
| Apr 2017 | -$132.60 K(-692.0%) | - | - |
| Sep 2016 | - | $15.70 K(>+9900.0%) | $15.70 K(-137.2%) |
| Sep 2015 | - | $0.00(-100.0%) | -$42.20 K(<-9900.0%) |
| Dec 2014 | - | -$42.20 K(<-9900.0%) | $100.00(-99.9%) |
| Sep 2014 | - | $100.00(-99.8%) | $130.90 K(+2466.7%) |
| Jun 2014 | - | $42.20 K(-52.4%) | $5100.00(>+9900.0%) |
| Dec 2013 | - | $88.60 K(-170.5%) | $0.00(-100.0%) |
| Sep 2013 | - | -$125.70 K(-438.8%) | -$88.60 K(-338.8%) |
| Jun 2013 | - | $37.10 K(>+9900.0%) | $37.10 K(-72.3%) |
| Sep 2012 | - | $0.00(0.0%) | $134.00 K(+0.3%) |
| Jun 2012 | - | $0.00(-100.0%) | $133.60 K(+496.4%) |
| Dec 2011 | $22.40 K(-99.6%) | - | - |
| Dec 2011 | - | $134.00 K(<-9900.0%) | $22.40 K(-99.5%) |
| Sep 2011 | - | -$400.00(-81.0%) | $4.97 M(+0.4%) |
| Jun 2011 | - | -$2100.00(-98.1%) | $4.96 M(-0.3%) |
| Mar 2011 | - | -$109.10 K(-102.1%) | $4.97 M(-2.3%) |
| Dec 2010 | $5.09 M(-2470.3%) | - | - |
| Dec 2010 | - | $5.09 M(<-9900.0%) | $5.09 M(+5880.1%) |
| Sep 2010 | - | -$18.40 K(-252.1%) | $85.10 K(+14.5%) |
| Jun 2010 | - | $12.10 K(+31.5%) | $74.30 K(+142.0%) |
| Mar 2010 | - | $9200.00(-88.8%) | $30.70 K(-114.3%) |
| Dec 2009 | -$214.70 K(-82.0%) | - | - |
| Dec 2009 | - | $82.20 K(-381.5%) | -$214.60 K(-50.8%) |
| Sep 2009 | - | -$29.20 K(-7.3%) | -$436.60 K(-69.7%) |
| Jun 2009 | - | -$31.50 K(-86.7%) | -$1.44 M(+1.3%) |
| Mar 2009 | - | -$236.10 K(+68.9%) | -$1.42 M(+18.8%) |
| Dec 2008 | -$1.20 M | - | - |
| Dec 2008 | - | -$139.80 K(-86.5%) | -$1.20 M(+12.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2008 | - | -$1.03 M(+7964.8%) | -$1.07 M(+1648.9%) |
| Jun 2008 | - | -$12.80 K(+17.4%) | -$61.00 K(+171.1%) |
| Mar 2008 | - | -$10.90 K(+0.9%) | -$22.50 K(-30.3%) |
| Dec 2007 | -$32.30 K(-98.0%) | - | - |
| Dec 2007 | - | -$10.80 K(-59.2%) | -$32.30 K(-82.3%) |
| Sep 2007 | - | -$26.50 K(-203.1%) | -$182.40 K(-84.7%) |
| Jun 2007 | - | $25.70 K(-224.2%) | -$1.19 M(-23.4%) |
| Mar 2007 | - | -$20.70 K(-87.1%) | -$1.56 M(-3.2%) |
| Dec 2006 | -$1.61 M(+5.4%) | - | - |
| Dec 2006 | - | -$160.90 K(-84.5%) | -$1.61 M(-5.9%) |
| Sep 2006 | - | -$1.04 M(+206.7%) | -$1.71 M(+19.6%) |
| Jun 2006 | - | -$338.10 K(+366.3%) | -$1.43 M(+1474.6%) |
| Mar 2006 | - | -$72.50 K(-72.4%) | -$90.80 K(-94.0%) |
| Dec 2005 | -$1.53 M(+137.5%) | - | - |
| Dec 2005 | - | -$262.40 K(-65.3%) | -$1.53 M(+12.8%) |
| Sep 2005 | - | -$756.70 K(-175.6%) | -$1.35 M(+42.5%) |
| Jun 2005 | - | $1.00 M(-166.4%) | -$949.00 K(-52.1%) |
| Mar 2005 | - | -$1.51 M(+1591.5%) | -$1.98 M(+208.3%) |
| Dec 2004 | -$642.30 K(+269.1%) | - | - |
| Dec 2004 | - | -$89.10 K(-74.8%) | -$642.30 K(+7.2%) |
| Sep 2004 | - | -$353.60 K(+1074.8%) | -$599.30 K(+66.1%) |
| Jun 2004 | - | -$30.10 K(-82.2%) | -$360.80 K(+2.5%) |
| Mar 2004 | - | -$169.50 K(+267.7%) | -$352.10 K(+102.5%) |
| Dec 2003 | -$174.00 K(+82.8%) | - | - |
| Dec 2003 | - | -$46.10 K(-59.9%) | -$173.90 K(+37.5%) |
| Sep 2003 | - | -$115.10 K(+437.9%) | -$126.50 K(+990.5%) |
| Jun 2003 | - | -$21.40 K(-346.0%) | -$11.60 K(-258.9%) |
| Mar 2003 | - | $8700.00(+569.2%) | $7300.00(-107.7%) |
| Dec 2002 | -$95.20 K(-212.9%) | - | - |
| Dec 2002 | - | $1300.00(-750.0%) | -$95.20 K(-8.1%) |
| Sep 2002 | - | -$200.00(-92.0%) | -$103.60 K(-501.6%) |
| Jun 2002 | - | -$2500.00(-97.3%) | $25.80 K(-153.3%) |
| Mar 2002 | - | -$93.80 K(+1221.1%) | -$48.40 K(-157.4%) |
| Dec 2001 | $84.30 K(-117.1%) | - | - |
| Dec 2001 | - | -$7100.00(-105.5%) | $84.30 K(-124.8%) |
| Sep 2001 | - | $129.20 K(-268.4%) | -$340.40 K(-30.6%) |
| Jun 2001 | - | -$76.70 K(-297.2%) | -$490.50 K(+10.8%) |
| Mar 2001 | - | $38.90 K(-109.0%) | -$442.80 K(-10.2%) |
| Dec 2000 | -$493.20 K(+454.2%) | - | - |
| Dec 2000 | - | -$431.80 K(+1966.0%) | -$493.10 K(+272.4%) |
| Sep 2000 | - | -$20.90 K(-27.9%) | -$132.40 K(+10.8%) |
| Jun 2000 | - | -$29.00 K(+154.4%) | -$119.50 K(+238.5%) |
| Mar 2000 | - | -$11.40 K(-84.0%) | -$35.30 K(-60.4%) |
| Dec 1999 | -$89.00 K(-51.8%) | - | - |
| Dec 1999 | - | -$71.10 K(+788.8%) | -$89.10 K(+314.4%) |
| Sep 1999 | - | -$8000.00(-114.5%) | -$21.50 K(-79.2%) |
| Jun 1999 | - | $55.20 K(-184.7%) | -$103.60 K(-18.9%) |
| Mar 1999 | - | -$65.20 K(+1762.9%) | -$127.80 K(-30.8%) |
| Dec 1998 | -$184.80 K(-134.1%) | - | - |
| Dec 1998 | - | -$3500.00(-96.1%) | -$184.80 K(+4.9%) |
| Sep 1998 | - | -$90.10 K(-390.6%) | -$176.20 K(-60.8%) |
| Jun 1998 | - | $31.00 K(-125.4%) | -$449.30 K(-207.6%) |
| Mar 1998 | - | -$122.20 K(-2496.1%) | $417.50 K(-23.1%) |
| Dec 1997 | $542.70 K(-131.1%) | - | - |
| Dec 1997 | - | $5100.00(-101.4%) | $542.70 K(+0.9%) |
| Sep 1997 | - | -$363.20 K(-140.5%) | $537.60 K(-40.3%) |
| Jun 1997 | - | $897.80 K(>+9900.0%) | $900.80 K(>+9900.0%) |
| Mar 1997 | - | $3000.00 | $3000.00 |
| Dec 1996 | -$1.74 M | - | - |
FAQ
- What is ImmunoPrecise Antibodies annual cash flow from investing activities?
- What is the all time high annual CFI for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies annual CFI year-on-year change?
- What is ImmunoPrecise Antibodies quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies quarterly CFI year-on-year change?
- What is ImmunoPrecise Antibodies TTM cash flow from investing activities?
- What is the all time high TTM CFI for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies TTM CFI year-on-year change?
What is ImmunoPrecise Antibodies annual cash flow from investing activities?
The current annual CFI of IPA is -$1.16 M
What is the all time high annual CFI for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high annual cash flow from investing activities is $5.09 M
What is ImmunoPrecise Antibodies annual CFI year-on-year change?
Over the past year, IPA annual cash flow from investing activities has changed by +$321.80 K (+21.76%)
What is ImmunoPrecise Antibodies quarterly cash flow from investing activities?
The current quarterly CFI of IPA is -$48.20 K
What is the all time high quarterly CFI for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high quarterly cash flow from investing activities is $5.09 M
What is ImmunoPrecise Antibodies quarterly CFI year-on-year change?
Over the past year, IPA quarterly cash flow from investing activities has changed by +$143.80 K (+74.90%)
What is ImmunoPrecise Antibodies TTM cash flow from investing activities?
The current TTM CFI of IPA is -$1.02 M
What is the all time high TTM CFI for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high TTM cash flow from investing activities is $5.09 M
What is ImmunoPrecise Antibodies TTM CFI year-on-year change?
Over the past year, IPA TTM cash flow from investing activities has changed by +$179.00 K (+14.89%)